Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Systemic tnf-blocking therapy does not modulate the synovial expression of the pro-inflammatory mediator HMGB1 in rheumatoid arthritis patients
Karolinska Inst, Stockholm, Sweden..
Karolinska Inst, Dept Med, Rheumatol Unit, Stockholm, Sweden..
Karolinska Inst, Dept Med, Rheumatol Unit, Stockholm, Sweden..
KTH, Superseded Departments (pre-2005), Biotechnology.
Show others and affiliations
2007 (English)In: Annals of the Rheumatic Diseases, ISSN 0003-4967, E-ISSN 1468-2060, Vol. 66, p. 189-189Article in journal, Meeting abstract (Other academic) Published
Place, publisher, year, edition, pages
B M J PUBLISHING GROUP , 2007. Vol. 66, p. 189-189
National Category
Clinical Medicine
Identifiers
URN: urn:nbn:se:kth:diva-242364ISI: 000253101100602OAI: oai:DiVA.org:kth-242364DiVA, id: diva2:1286227
Conference
Annual European Congress of Rheumatology (EULAR 2007), JUN 13-16, 2007, Barcelona, SPAIN
Note

QC 20190206

Available from: 2019-02-06 Created: 2019-02-06 Last updated: 2019-02-06Bibliographically approved

Open Access in DiVA

No full text in DiVA

Search in DiVA

By author/editor
Lindberg, J.
By organisation
Biotechnology
In the same journal
Annals of the Rheumatic Diseases
Clinical Medicine

Search outside of DiVA

GoogleGoogle Scholar

urn-nbn

Altmetric score

urn-nbn
Total: 2 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf